Neoadjuvant therapy with intensity-modulated radiotherapy combined with S-1 for borderline-resectable pancreatic cancer.

Yusuke OkamuraRyuta NishitaiNaoya SasakiHitoshi ItoTakashi SakamotoYoshio ItokawaMasanori KusumotoYoshitaka NakaiToshihide YamaokaDai Manaka

Published in: Asia-Pacific journal of clinical oncology (2024)

NAC-IMRT showed outstanding clinical efficacy with acceptable tolerability in patients with BRPC, including geriatric patients.

Keyphrases